Flush Advanced+ is a science-backed solution for recurrent urinary tract infections (UTIs), now available online at Uqora.com. Following the success of Uqora ® Flush, America’s #1 Urinary Tract Drink ...

SAN DIEGO--(BUSINESS WIRE)--Uqora, the rapidly growing and cutting-edge urinary tract health brand, today announces the launch of Flush Advanced+, a science-backed solution for recurrent urinary tract ...

Approximately 60% of women will experience a UTI in their lifetime2 — Flush Advanced+ helps to reduce the risk of recurrent UTIs in healthy women‡, delivering an effective, comprehensive solution to ...

Gaffin is an infectious disease physician in New Jersey. Recently, a former patient contacted me about his wife. “She had a recent stroke which has caused cognitive decline along with slow-growing ...

• Regular exercises to strengthen the muscles that support the bladder, uterus, and bowel — known as 'pelvic floor muscle training' or PFMT — with or without complementary therapies (including ...

Data from a recent meta-analysis suggest that urinary tract infections after bladder resection are common. Clinicians should consider 5 key patient factors to help prevent them. Evaluating the Use of ...

From the Uresta Starter Kit, a woman selects one of the bladder support device sizes to find her best fit for comfort and effectiveness. A femtech startup is bringing a non-surgical solution for women ...

To make life easier for people with a common bladder condition, Medtronic is digging in far away from urinary tract. Treatment for urinary urge incontinence can require pads, absorbent underwear and ...

Dipa Kamdar does not work for, consult, own shares in or receive funding from any company or organization that would benefit from this article, and has disclosed no relevant affiliations beyond their ...

The US Food and Drug Administration has approved Johnson & Johnson’s drug delivery system for a type of bladder cancer, offering a potential surgery-free option for patients. The drug release system, ...

Inlexzo is a new treatment for a type of bladder cancer in adults that hasn’t spread to the muscles and doesn’t respond to Bacillus Calmette-Guérin (BCG) therapy. It’s approved for treating non-muscle ...